招聘
Mainz, Germany | full time | Job ID: 11167
About the Role:
In this pivotal role, you will take ownership of specific sub-processes within the Lead-to-Cash (L2C) framework—such as Lead-to-Order, Order-to-Bill, Bill-to-Cash, and Legal Entity Lifecycle Management. You will drive operational excellence, digital transformation, and compliance across BioNTech’s global organization. Collaborating closely with the Global Process Owner L2C, you will define and execute the L2C strategy while ensuring alignment, standardization, and continuous improvement of processes. This role offers a unique opportunity to gain valuable insights into pharmaceutical commercial activities such as product launches, market access, government price reporting, and Gross-to-Net reporting.
Your Contribution:
-
Take ownership of assigned sub-processes within the L2C framework to align with global standards, regulatory requirements, and organizational goals while driving continuous improvement
-
Co-lead S/4HANA implementation projects (including global rollouts), focusing on SD, MM, FI modules and relevant satellite systems/interfaces
-
Collaborate with global stakeholders to standardize processes and integrate digital solutions for enhanced data visibility and operational performance
-
Support the Global Process Owner L2C in defining the vision, strategy, and governance framework for global L2C processes
-
Co-lead governance meetings, contribute to policy design, and serve as a key decision-maker to ensure alignment with global standards and budgets
-
Act as a liaison between regional process managers and leadership teams to incorporate stakeholder needs into global initiatives
-
Provide strategic guidance on L2C process improvements tailored to business needs while building strong relationships with internal/external stakeholders
-
Define KPIs for assigned sub-processes to measure performance and drive data-driven continuous improvement initiatives
-
Leverage analytics to ensure data quality and prepare impactful reports/dashboards for senior leadership
A Good Match:
-
Completed Bachelor's or Master's Degree in Business, Finance, Supply Chain or a related field; MBA or equivalent preferred
-
5+ years of experience in Lead-to-Cash/Order-to-Cash or related fields within multinational environments; experience in listed companies within the pharmaceutical/medtech/life science industry is advantageous
-
Proven ability to lead cross-regional/cross-functional teams in a matrixed global environment while fostering collaboration and adherence to process standards
-
Hands-on experience with S/4HANA implementations (SD, MM, FI modules); familiarity with ERP systems like SAP or Oracle is essential
-
Strategic mindset with expertise in defining long-term visions and aligning global processes with organizational goals while anticipating challenges in diverse markets
-
Strong skills in leveraging data analytics/KPIs to monitor process performance and drive LEAN-based improvements
-
Exceptional communication skills to engage stakeholders across diverse teams, cultures, and senior leadership levels
-
In-depth knowledge of process governance/compliance with global regulatory standards (e.g., GxP, IFRS, SOX)
-
Fluent English skills (written and spoken)
This role ensures that end-to-end Lead-to-Cash processes are integrated seamlessly with business objectives and regulatory requirements during project implementation—and beyond.
Your Benefits:
It's our priority to support you:
- Your flexibility: flexible hours | vacation account
- Your growth: Digital Learning | Performance & talent development | leadership development | Apprenticeships | LinkedIn Learning
- Your value: Your voice at the table | Culture on an equal footing | Opportunities to shape & impact | Support for your full potential
- Your health and lifestyle: Company bike
- Your mobility: Job ticket | Deutschlandticket
- Your life phases: Employer-funded pension | Childcare
Apply now
- We look forward to your application!
Apply to our Mainz, Germany location by sending us your documents via our online form. For any questions, contact our talent acquisition team on: + 49 (0) 6131-9084-1291 (Monday-Friday from 1 PM to 3 PM CET).
Job ID 11167 (please always specify if you have any questions)
By submitting your application, you acknowledge that a background check will be conducted as part of the recruitment process in accordance with applicable laws and regulations. If you are considered for the position, BioNTech will conduct the background check through our service provider ‘Hire Right’. You will be informed accordingly by your BioNTech-Recruiter.
总浏览量
0
申请点击数
0
模拟申请者数
0
收藏
0
相似职位

General Manager - Franchise
Hilton · Gulf Shores, Alabama, United States

Gestionnaire de studio (Studio Manager)
Lucid Motors · Canada

O2C Delivery Manager
ABB · Bangalore, Karnātaka, India

Regional Facility Manager
Curtiss-Wright · Client Site - USA - CA - Ontario - 1425 Toyota Way

Commercial Manager
Raytheon (RTX) · Winnersh; Harlow
关于BioNTech

BioNTech
PublicBioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
1,001-5,000
员工数
Mainz that develops immunotherapies
总部位置
$21.7B
企业估值
评价
4.0
10条评价
工作生活平衡
2.8
薪酬
3.7
企业文化
4.2
职业发展
3.5
管理层
3.3
78%
推荐给朋友
优点
Innovative and cutting-edge technology projects
Supportive and collaborative team environment
Meaningful and impactful work with strong mission
缺点
Long working hours and high workload
Fast-paced environment can be stressful
High pressure and expectations
薪资范围
38个数据点
Mid/L4
Senior/L5
Director
Mid/L4 · MANAGER, DIGITAL SYSTEMS COMPLIANCE
1份报告
$143,000
年薪总额
基本工资
$110,000
股票
-
奖金
-
$143,000
$143,000
面试经验
1次面试
难度
3.0
/ 5
时长
14-28周
面试流程
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Final Interview
6
Offer
常见问题
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
Problem Solving
新闻动态
New Drugs for Pancreatic Cancer Show Remarkable Promise for Deadly Disease - WSJ
WSJ
News
·
4d ago
Investigational Pancreatic Cancer Vaccine Shows Lasting Results in Early Trial, Supporting Continued Testing - Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
News
·
6d ago
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
Oncodaily
News
·
1w ago
BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story - simplywall.st
simplywall.st
News
·
1w ago